|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.288 GBX | +11.38% |
|
+17.48% | -39.61% |
| 20/11 | Poolbeg Pharma Secures European Patent for Severe Influenza Drug Candidate | MT |
| 20/11 | AIM WINNERS & LOSERS: Artisanal in shutdown hit; Solid State deal wins | AN |
Analyst Reco.
Search
No results for this search
- Stock Market
- Equities
- POLB Stock
- News Poolbeg Pharma PLC
- Analyst Reco.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition